Astrid Dalhaug
Carsten Nieder,
Luka Stanisavljevic,
Astrid Dalhaug,
Ellinor Christin Haukland
:
Impact of Body Mass Index on Survival After Docetaxel Chemotherapy for Metastatic Castration‐resistant Prostate Cancer
Carsten Nieder,
Siv Gyda Aanes,
Astrid Dalhaug,
Ellinor Christin Haukland
:
Sex Differences in Presentation, Treatment, and Survival in Patients Receiving Palliative (Chemo)Radiotherapy for Non-Small Cell Lung Cancer
Carsten Nieder,
Luka Stanisavljevic,
Astrid Dalhaug,
Ellinor Christin Haukland
:
Survival after docetaxel for metastatic castration-resistant prostate cancer in a rural health care setting
Katarina Puco,
Gro Live Fagereng,
Sigmund Brabrand,
Pitt Niehusmann,
Egil Støre Blix,
Eli Sihn Samdal Steinskog
et al.:
IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results
Carsten Nieder,
Ellinor Christin Haukland,
Bård Mannsåker,
Astrid Dalhaug
:
Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation
Carsten Nieder,
Astrid Dalhaug
:
Prognostic factors and independent validation of a risk stratification model in octogenarian patients irradiated for brain metastases
Carsten Nieder,
Bård Mannsåker,
Astrid Dalhaug
:
Percent of remaining life on palliative radiation treatment: solely a function of fractionation?
Carsten Nieder,
Ellinor Christin Haukland,
Bård Mannsåker,
Astrid Dalhaug
:
The LabPS score: Inexpensive, Fast, and Site-agnostic Survival Prediction
Carsten Nieder,
Luka Stanisavljevic,
Astrid Dalhaug,
Ellinor Christin Haukland
:
Feasibility and efficacy of early docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in a rural health care setting
Carsten Nieder,
Astrid Dalhaug,
Bård Mannsåker
:
Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain Involvement
Elin Aamdal,
Eva Skovlund,
Kari Dolven Jacobsen,
Oddbjørn Straume,
Christian Kersten,
Oluf Herlofsen
et al.:
Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
Carsten Nieder,
Astrid Dalhaug,
Ellinor Christin Haukland
:
The LabBM score is an excellent survival prediction tool in patients undergoing palliative radiotherapy
Carsten Nieder,
Astrid Dalhaug,
Ellinor Christin Haukland
:
Recursive partitioning analysis of systemic therapy after radiotherapy in patients with brain metastases
Elin Aamdal,
Kari Dolven Jacobsen,
Oddbjørn Straume,
Christian Kersten,
Oluf Herlofsen,
Jarle Karlsen
et al.:
Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up
Carsten Nieder,
Astrid Dalhaug,
Ellinor Christin Haukland
:
Is there a seasonal variation of survival after systemic chemotherapy for metastatic castration-resistant prostate cancer in a rural part of North Norway?
Carsten Nieder,
Bård Mannsåker,
Astrid Dalhaug
:
Independent external validation of a score predicting survival after radiotherapy for bone metastases and expansion to patients treated with single fraction radiotherapy
Carsten Nieder,
Astrid Dalhaug,
Ellinor Christin Haukland
:
Feasibility and efficacy of sequential systemic therapy for metastatic castration-resistant prostate cancer in a rural health care setting
Carsten Nieder,
Astrid Dalhaug,
Adam Pawinski
:
Management of patients with metastatic renal cell cancer and bone metastases
Carsten Nieder,
Astrid Dalhaug,
Adam Pawinski
:
Confirmatory analysis of QUARTZ study results: Survival prolongation after whole-brain radiotherapy
Carsten Nieder,
Astrid Dalhaug,
Ellinor Christin Haukland,
Jan Norum
:
Management of patients with metastatic prostate cancer (mPC) in a rural part of North Norway with a scattered population: does living near the department of oncology translate into a different pattern of care and survival?
Carsten Nieder,
Astrid Dalhaug,
Adam Pawinski
:
External Validation of the LabBM Score in Patients With Brain Metastases
Carsten Nieder,
Astrid Dalhaug,
Adam Pawinski
:
Contribution of serum biomarkers to prognostic assessment in patients with oligometastatic prostate cancer
Carsten Nieder,
Astrid Dalhaug,
Adam Pawinski
:
Serum lactate dehydrogenase contributes to prognostic assessment in patients with oligometastatic cancer and brain involvement
Carsten Nieder,
Rosalba Yobuta,
Bård Mannsåker,
Astrid Dalhaug
:
How should palliative thoracic radiotherapy be fractionated for octogenarians with Lung cancer?
In Vivo 2018 ARKIV
Carsten Nieder,
Terje Tollåli,
Ellinor Christin Haukland,
Anne Reigstad,
Liv Randi Flatøy,
Astrid Dalhaug
:
A Four-Tiered Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer
Carsten Nieder,
Astrid Dalhaug,
Ellinor Christin Haukland,
Kirsten Engljähringer
:
Patient-reported symptom burden, rate of completion of palliative radiotherapy and 30-day mortality in two groups of cancer patients managed with or without additional care by a multidisciplinary palliative care team
Carsten Nieder,
Thomas A kämpe,
Adam Pawinski,
Astrid Dalhaug
:
Patient-reported symptoms before palliative radiotherapy predict survival differences
Carsten Nieder,
Terje Tollåli,
Ellinor Haukland,
Anne Reigstad,
Liv Randi Flatøy,
Astrid Dalhaug
:
External validation of a prognostic score for patients receiving palliative thoracic radiotherapy for lung cancer
Carsten Nieder,
Astrid Dalhaug,
Ellinor Haukland,
Bård Mannsåker,
Adam Pawinski
:
Prognostic Impact of the Tumor Marker CA 15-3 in Patients
With Breast Cancer and Bone Metastases Treated With
Palliative Radiotherapy
Carsten Nieder,
Mohsan Ali Syed,
Astrid Dalhaug,
Adam Pawinski,
Jan Norum
:
Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region
Carsten Nieder,
Bård Mannsåker,
Astrid Dalhaug,
Adam Pawinski,
Ellinor Christin Haukland
:
The Glasgow prognostic score: Useful information when prescribing palliative radiotherapy
Carsten Nieder,
Astrid Dalhaug,
Ellinor Haukland,
Bård Mannsåker,
Adam Pawinski
:
Contemporary radiooncological management of bone metastases from breast
cancer: factors associated with prescription of different fractionation regimens(short or long course) in a rural part of North Norway with long travel distance
Carsten Nieder,
Bård Mannsåker,
Astrid Dalhaug,
Adam Pawinski,
Ellinor Haukland
:
Palliative radiotherapy in cancer patients with increased serum c-reactive protein level
Carsten Nieder,
Astrid Dalhaug,
Adam Pawinski,
Bård Mannsåker,
Ellinor Haukland
:
Survival after palliative radiotherapy in patients with breast cancer and bone-only metastases
Carsten Nieder,
Ellinor Haukland,
Bård Mannsåker,
Adam Pawinski,
Astrid Dalhaug
:
Early palliative radiation therapy in patients with newly diagnosed cancer: Reasons, clinical practice, and survival
Carsten Nieder,
Astrid Dalhaug,
Adam Pawinski,
Ellinor Haukland,
Bård Mannsåker,
Kirsten Engljähringer
:
Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team in patients with newly diagnosed cancer: A retrospective matched pairs comparison
Carsten Nieder,
Kent Angelo,
Astrid Dalhaug,
Adam Pawinski,
Ellinor Haukland,
Jan Norum
:
Palliative radiotherapy during the last month of life: Predictability for referring physicians and radiation oncologists
Carsten Nieder,
Astrid Dalhaug,
Ellinor Haukland,
Bård Mannsåker,
Adam Pawinski
:
Tumor marker analyses in patients with brain metastases: patterns of practice and implications for survival prediction research
Carsten Nieder,
Terje Tollåli,
Astrid Dalhaug,
Ellinor Haukland,
Gro Aandahl,
Adam Pawinski
et al.:
Active anticancer treatment during the final month of life in patients with non-small cell lung cancer
Kent Angelo,
Jan Norum,
Astrid Dalhaug,
Adam Pawinski,
Gro Aandahl,
Ellinor Haukland
et al.:
Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy
Anticancer Research 2014 ARKIV
Carsten Nieder,
Terje Tollåli,
Anne Reigstad,
Adam Pawinski,
Ellinor Haukland,
Astrid Dalhaug
:
Oligometastatic Non-Small Cell Lung Cancer: A Significant Entity outside of Specialized Cancer Centers?
Astrid Dalhaug,
Adam Pawinski,
Jan Norum,
Carsten Nieder
:
Presentation and course of brain metastases from breast cancer in a paranoid-schizophrenic patient: A case report
Carsten Nieder,
Kent Angelo,
Astrid Dalhaug,
Adam Pawinski,
Gro Aandahl,
Ellinor Haukland
et al.:
Palliative Radiotherapy with or without Additional Care by a Multidisciplinary Palliative Care Team: A Retrospective Comparison
Kent Angelo,
Astrid Dalhaug,
Adam Pawinski,
Ellinor Haukland,
Carsten Nieder
:
Survival Prediction Score: A Simple but Age-Dependent Method Predicting Prognosis in Patients Undergoing Palliative Radiotherapy
Carsten Nieder,
Kirsten Marienhagen,
Astrid Dalhaug,
Gro Aandahl,
Ellinor Haukland,
Adam Pawinski
:
Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases
Carsten Nieder,
Kirsten Marienhagen,
Astrid Dalhaug,
Gro Aandahl,
Ellinor Haukland,
Adam Pawinski
:
Prognostic models predicting survival of patients with brain metastases: Integration of lactate dehydrogenase, albumin and extracranial organ involvement
Carsten Nieder,
Jan Norum,
Astrid Dalhaug,
Gro Aandahl,
Kirsten Engljähringer
:
Best supportive care in patients with brain metastases and adverse prognostic factors: development of improved decision aids
Kjetil Tasken,
Hege Elisabeth Giercksky Russnes,
Eline Aas,
Line Bjørge,
Egil Støre Blix,
Terje C. Ahlquist
et al.:
A national precision cancer medicine implementation initiative for Norway
Åslaug Helland,
Hege Elisabeth Giercksky Russnes,
Gro Live Fagereng,
Khalid Ibrahim Al-Shibli,
Yvonne Andersson,
Thomas Berg
et al.:
Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway (Journal of Translational Medicine, (2022), 20, 1, (225), 10.1186/s12967-022-03432-5)
Åslaug Helland,
Hege Elisabeth Giercksky Russnes,
Gro Live Fagereng,
Khalid Ibrahim Al-Shibli,
Yvonne Andersson,
Thomas Berg
et al.:
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
The 50 latest publications is shown on this page. See all publications in Cristin here →